Changeflow GovPing Healthcare & Life Sciences Fish Totivirus Patent Granted to Pharmaq AS
Routine Rule Added Final

Fish Totivirus Patent Granted to Pharmaq AS

Favicon for changeflow.com USPTO Patent Grants - Peptides (C07K)
Published
Detected
Email

Summary

The USPTO granted Patent US12606875B2 to Pharmaq AS on April 21, 2026, covering a novel fish Totivirus that causes mortality in fish and methods for detecting the virus. The patent names inventors Stian Nylund, Liv Sandlund, and Arnfinn L. Okland. The filing date was February 4, 2020, under Application No. 17433416, with 22 claims registered.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO granted Patent US12606875B2 to Pharmaq AS on April 21, 2026, covering a novel fish Totivirus and associated detection methods. The patent contains 22 claims across multiple CPC classifications including C07K 14/005, C07K 14/08, C07K 14/165, C12N 7/00, and C12N 2770/20021.

Pharmaq AS now holds enforceable patent rights to this fish virus detection technology in the United States. Competitors developing similar fish health diagnostics or vaccines targeting Totivirus should conduct freedom-to-operate analyses to assess potential infringement exposure.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Fish Totivirus

Grant US12606875B2 Kind: B2 Apr 21, 2026

Assignee

Pharmaq AS

Inventors

Stian Nylund, Liv Sandlund, Arnfinn L. Okland

Abstract

The invention relates to a novel fish virus, indicated to be a Totivirus, which causes mortality in fish, and to methods of detecting said virus in fish, and related uses.

CPC Classifications

C07K 14/005 C07K 14/08 C07K 14/165 C12N 7/00 C12N 2770/20021

Filing Date

2020-02-04

Application No.

17433416

Claims

22

View original document →

Parties

Get daily alerts for USPTO Patent Grants - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12606875B2

Who this affects

Applies to
Pharmaceutical companies Manufacturers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent issuance Virus detection methods Biotechnology
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Public Health Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!